Bone safety of dual-release hydrocortisone in patients with autoimmune primary adrenal insufficiency

BACKGROUND: Conventional glucocorticoids (C-GC) replacement regimens have a detrimental effect on skeletal health in patients with adrenal insufficiency (AI), ultimately leading to an increased fracture risk. The novel dual-release hydrocortisone (DR-HC) formulations are characterized by a more favo...

Descripción completa

Detalles Bibliográficos
Autores principales: Bioletto, Fabio, Barale, Marco, Parasiliti-Caprino, Mirko, Giannelli, Jacopo, Campioni, Lorenzo, Cappiello, Vincenzo, Di Carlo, Maria Chiara, Ghigo, Ezio, Procopio, Massimo, Giordano, Roberta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10519793/
https://www.ncbi.nlm.nih.gov/pubmed/37766685
http://dx.doi.org/10.3389/fendo.2023.1234237

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10519793/
https://www.ncbi.nlm.nih.gov/pubmed/37766685
http://dx.doi.org/10.3389/fendo.2023.1234237

Ejemplares similares